{
    "nctId": "NCT00502736",
    "briefTitle": "A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.",
    "officialTitle": "An Open Label Study to Assess the Effect of Intravenous Loading Doses of Bondronat on Bone Pain in Patients With Breast Cancer and Skeletal Metastases",
    "overallStatus": "COMPLETED",
    "conditions": "Pain; Bone Neoplasms; Neoplasm Metastasis",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 13,
    "primaryOutcomeMeasure": "Pain and analgesic consumption",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* female patients, \\>=18 years of age;\n* breast cancer;\n* bone metastases;\n* moderate to severe pain;\n* adequate renal function.\n\nExclusion Criteria:\n\n* bisphosphonate treatment within 3 weeks of study enrollment.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}